Table 3.
Mixed‐effects logistic regression analyses assessing the risk of lactic acidosis
| Covariate | OR | P‐value | 95% CI | |
|---|---|---|---|---|
| Univariate analysis | ||||
| AKI Stage | ||||
| 1 | 3.2 | .001 | 1.6‐6.6 | |
| 2 | 9.6 | <.001 | 4.7‐19.3 | |
| 3 | 15.9 | <.001 | 7.7‐32.8 | |
| Metformin | 1.8 | .011 | 1.1‐2.9 | |
| Type 2 Diabetes | 2.3 | .018 | 1.2‐4.8 | |
| Multivariate analysis | ||||
| AKI Stage | ||||
| 1 | 3.0 | .002 | 1.5‐6.1 | |
| 2 | 9.4 | <.001 | 4.7‐18.8 | |
| 3 | 16.1 | <.001 | 7.9‐33.0 | |
| CKD Stage 4/5 | 3.6 | .028 | 1.1‐11.6 | |
| Metformin | 2.3 | .002 | 1.4‐3.8 |
Abbreviations: AKI, acute kidney injury; CI, confidence interval; OR, odds ratio.